Latest Revenue Growth News

Domain Holdings Australia Limited has reported a robust half-year performance with a 10% increase in revenue and a 46.4% jump in net profit after tax for the period ending December 31, 2024. The company also announced a fully franked interim dividend, signaling confidence in its ongoing growth trajectory.

Temple & Webster reported a record half-year revenue of $314 million for H1 FY25, up 24% year-on-year, driven by strong customer growth and improved margins. The company remains on track to exceed $1 billion in annual revenue within the next few years.

Downer EDI reports a robust half-year financial performance for December 2024, with notable increases in profit and earnings per share, despite suspending its Dividend Reinvestment Plan.

ASX Limited delivered a robust first half in 2025 with record operating revenue and a 10% rise in underlying NPAT, underscoring its strategic focus on technology modernisation and disciplined cost management.

ASX Limited has reported a robust first half of FY25 with record operating revenue and a near 10% rise in underlying net profit, underpinned by strong growth across key business segments and a strategic focus on technology modernization.

Temple & Webster has posted a robust 24% revenue increase in H1 FY25, alongside record profitability and market share gains, signaling strong momentum despite economic headwinds.

Temple & Webster Group Ltd delivered a robust half-year performance with revenues climbing 24% to $313.7 million and profit after tax more than doubling to $9 million, underpinned by strategic growth initiatives and operational efficiencies.

ASX Limited reported a solid half-year performance for 1H25, with operating revenue up 5.9% to $541.9 million and an interim dividend increase to 111.2 cents per share. The company continues to invest heavily in technology upgrades while navigating ongoing regulatory scrutiny.

Treasury Wine Estates reports a robust first half of 2025, driven by luxury portfolio growth and DAOU integration, while premium segments face headwinds.

Telix Pharmaceuticals has gained UK MHRA approval for Illuccix, its advanced prostate cancer PET imaging agent, promising to alleviate supply shortages and improve diagnostic accuracy across the UK.

Alliance Aviation Services has reported a robust half-year performance with a 9.5% increase in statutory profit before tax and record flight hours, underpinned by fleet expansion and strong wet lease demand.

Alliance Aviation Services reported an 11.3% revenue increase to $333 million and a 9.9% rise in net profit to $28.9 million for H1 FY2025, navigating challenges from industrial action and contract reductions.